---
figid: PMC8074527__gr3_lrg
figlink: pmc/articles/PMC8074527/figure/f0015/
number: Fig. 3
caption: Critical steps of SARS-CoV-2 infection involving lipid homeostasis. Some
  key steps of SARS-CoV-2 infection, ranging from the virus life cycle to the inflammatory
  response, can be affected by targeting the mevalonate pathway, making it a potential
  therapeutic target to counteract COVID-19.S, Spike protein; M, Membrane proteins;
  E, Envelope protein; N, Nucleocapsid protein; ER, Endoplasmic reticulum; DMVs, Double
  Membrane vesicles; CVDs, Cardiovascular diseases.
pmcid: PMC8074527
papertitle: 'Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts
  and potential therapeutic targets.'
reftext: Maria Chiara Proto, et al. Prog Lipid Res. 2021 Apr 26 ;82:101099-101099.
pmc_ranked_result_index: '5692'
pathway_score: 0.8966112
filename: gr3_lrg.jpg
figtitle: Critical steps of SARS-CoV-2 infection involving lipid homeostasis
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8074527__gr3_lrg.html
  '@type': Dataset
  description: Critical steps of SARS-CoV-2 infection involving lipid homeostasis.
    Some key steps of SARS-CoV-2 infection, ranging from the virus life cycle to the
    inflammatory response, can be affected by targeting the mevalonate pathway, making
    it a potential therapeutic target to counteract COVID-19.S, Spike protein; M,
    Membrane proteins; E, Envelope protein; N, Nucleocapsid protein; ER, Endoplasmic
    reticulum; DMVs, Double Membrane vesicles; CVDs, Cardiovascular diseases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - MYD88
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - ACE2
  - Cholesterol
  - fatty
  - Dyslipidemia
genes:
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR/MyD88
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR/MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: andTLR/MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
chemicals:
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: fatty
  source: MESH
  identifier: D005227
diseases:
- word: Dyslipidemia
  source: MESH
  identifier: D050171
---
